MYST乙转移酶是SETBP1-突变白血病中可向的治疗漏洞
bioRxiv : the preprint server for biology
|January 16, 2026
概括
在SET结合蛋白1 (SETBP1) 突变驱动高风险的骨髓瘤恶性瘤. 用抑制剂向MYST乙转移酶有效控制了临床前模型中的SETBP1-突变白血病,提供了一个有前途的新疗法.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 在SET结合蛋白1 (SETBP1) 中的突变与骨髓性恶性瘤的预后不佳有关.
- 这些突变稳定了SETBP1,通过不清楚的机制促进了原始基因表达程序.
研究的目的:
- 研究MYST乙转移酶复合体在SETBP1-突变骨髓性恶性瘤中的作用.
- 评估MYST抑制剂作为SETBP1突变白血病的治疗策略.
主要方法:
- 蛋白质组查以确定SETBP1相互作用的蛋白质.
- 在SETBP1目标基因中分析MYST复合体局部化和基因素乙化.
- 用MYST抑制剂进行SETBP1-突变骨髓原体的体外治疗.
- 在体内研究中,使用合成的SETBP1突变白血病小鼠模型和患者衍生异种移植 (PDX) 模型,用MYST抑制剂PF-9363.3治疗.
主要成果:
- SETBP1与MYST乙转移酶复合体 (KAT6A,KAT7) 相互作用.
- 突变的SETBP1增强了MYST复合体的招募,以准像霍克萨集群这样的基因,增加了基因素乙化和基因表达.
- 在体外,MYST 抑制剂会降低目标基因表达.
- 在SETBP1突变白血病的小鼠中,PF-9363治疗导致了完全的血液学控制和增加生存率,并且在PDX模型中有效.
结论:
- MYST乙转移酶是SETBP1-突变骨髓性恶性瘤中转录的关键驱动因素.
- 在临床前情况下,MYST抑制剂对SETBP1突变白血病具有显著的疗效.
- 在SETBP1突变恶性瘤中,MYST抑制剂是临床转化中的有希望的治疗标.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Phase II Reactions: Acetylation Reactions
760
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
760
ATP Synthase: Structure
15.2K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
15.2K
Allosteric Proteins-ATCase
6.5K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.5K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


